Cardiometabolic multimorbidity is common among patients with psoriasis and is associated with poorer outcomes compared to those without comorbidity.

Clinton W Enos Vanessa L Ramos Robert R McLeanTin-Chi LinNicole FosterBlessing Dube Abby S Van Voorhees

Published in: The Journal of dermatological treatment (2022)

Multimorbidity in psoriasis may decrease the likelihood of achieving treatment response to biologic therapy and should be considered when discussing treatment expectations with patients.

Keyphrases

end stage renal disease
chronic kidney disease
ejection fraction
rheumatoid arthritis
newly diagnosed
stem cells
prognostic factors
peritoneal dialysis
metabolic syndrome
weight loss